IP Library Patent Application 12165361
Patent Application
App. No. 12/165,361

Prediction and Prevention of Cardiovascular Insult

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/165,361
Abstract

In a method of providing therapy to a patient to prevent an occurrence of a dangerous cardiac event, a cardiac signal sensed over multiple cardiac cycles is received. A risk of impending cardiovascular insult is determined, using the received cardiac signal, by assessing an indicator of proarrhythmogenic substrate and a change in sympathovagal balance. A therapy comprising acupuncture to modulate sympathovagal balance is administered based on the determined risk.

Claims (29)

1 . A method of providing therapy to a patient to prevent an occurrence of a dangerous cardiac event, the method comprising:

receiving a cardiac signal sensed over multiple cardiac cycles;

determining, using the received cardiac signal, a risk of impending cardiovascular insult by assessing an indicator of proarrhythmogenic substrate and a change in sympathovagal balance; and

administering, based on the determined risk, a therapy comprising acupuncture to modulate sympathovagal balance.

2 . The method of claim 1 , further comprising detecting, using the received cardiac signal, a cardiac instability trigger for use in determining the risk of cardiovascular insult.

3 . The method of claim 2 , wherein the cardiac instability trigger is one or more ectopic beats.

4 . The method of claim 1 , wherein the indicator of proarrhythmogenic substrate is an alternans burden that exceeds a predetermined threshold.

5 . The method of claim 4 , wherein in the alternans burden is a repolarization alternans burden determined from the cardiac signal.

6 . The method of claim 4 , wherein in the alternans burden is a QRS alternans burden determined from the cardiac signal.

7 . The method of claim 4 , wherein in the alternans burden is a mechanical alternans burden determined from the cardiac signal.

8 . The method of claim 1 , wherein the indicator of proarrhythmogenic substrate is a hypertension burden determined from the cardiac signal.

9 . The method of claim 1 , wherein the indicator of proarrhythmogenic substrate is one or more delayed afterdepolarizations, determined from the cardiac signal, that exceed a predetermined threshold.

10 . The method of claim 1 , wherein the indicator of proarrhythmogenic substrate is a QT interval change that exceeds a predetermined threshold.

11 . The method of claim 1 , wherein the change in sympathovagal balance is estimated from a heart rate variability measurement determined from the cardiac signal.

12 . The method of claim 1 , wherein the change in sympathovagal balance is estimated from a heart rate increase measurement determined from the cardiac signal.

13 . The method of claim 1 , wherein the therapy modulates sympathovagal balance by activating parasympathetic drive.

14 . The method of claim 1 , wherein the acupuncture comprises electro-acupuncture applied to one or more cardiovascular acupoints.

15 . The method of claim 1 , wherein the acupuncture comprises magneto-acupuncture applied to one or more cardiovascular acupoints.

16 . The method of claim 1 , wherein the cardiac signal is an electrocardiogram signal.

17 . The method of claim 1 , wherein the cardiac signal is a blood pressure signal.

18 . The method of claim 1 , wherein the impending cardiovascular insult is arrhythmia.

19 . The method of claim 1 , wherein the impending cardiovascular insult is acute myocardial ischemia.

20 . The method of claim 1 , further comprising initiating an alarm to alert an emergency responder to the impending cardiovascular insult.

21 . The method of claim 1 , further comprising issuing an alert in a manner that allows a preventative action to be taken to prevent the dangerous cardiac event.

22 . The method of claim 21 , wherein the preventative action comprises donning a wearable external defibrillator, and wherein the patient performs the action in response to the alert.

23 . A system for providing therapy to prevent an occurrence of a dangerous cardiac event, comprising:

a monitoring component that receives a cardiac signal sensed over multiple cardiac cycles;

a processing component that determines, using the received cardiac signal, a risk of impending cardiovascular insult by assessing an indicator of proarrhythmogenic substrate and a change in sympathovagal balance; and

a therapy component that administers, based on the determined risk a therapy comprising acupuncture to modulate sympathovagal balance.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 24, 2010
From: PARTNERS FOR GROWTH II, L.P.
To: TRANSOMA MEDICAL, INC.
Reel/Frame 024588/0100 →
FORECLOSURE Recorded Mar 23, 2010
From: TRANSOMA MEDICAL, INC.
To: DATA SCIENCES INTERNATIONAL, INC.
Reel/Frame 024120/0696 →
SECURITY AGREEMENT Recorded May 14, 2009
From: TRANSOMA MEDICAL, INC.
To: PARTNERS FOR GROWTH II, L.P.
Reel/Frame 022678/0382 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2008
From: BROCKWAY, MARINA V.; BROCKWAY, BRIAN P.
To: TRANSOMA MEDICAL, INC.
Reel/Frame 021737/0714 →